By Lauraann Wood ( May 14, 2020, 9:43 PM EDT) -- Drug manufacturing company OncoGenerix USA Inc. can't dodge accusations that it ruined a drug developer's shot at $10 million in milestone payments by misrepresenting its ability and willingness to help produce a new cancer treatment, an Illinois federal judge said Wednesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.